Anthony J. Dalby
Publications by Year
Research Areas
Antiplatelet Therapy and Cardiovascular Diseases, Acute Myocardial Infarction Research, Lipoproteins and Cardiovascular Health, Atrial Fibrillation Management and Outcomes, Coronary Interventions and Diagnostics
Most-Cited Works
- → Vorapaxar in the Secondary Prevention of Atherothrombotic Events(2012)932 cited
- → Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization(2012)865 cited
- → Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38(2008)756 cited
- → Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease(2016)385 cited
- → Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial(2019)322 cited
- → Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality(2011)182 cited
- → Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y 12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54(2015)164 cited
- → Effect of Alirocumab on Mortality After Acute Coronary Syndromes(2019)140 cited
- → Prospective Evaluation of the Prognostic Implications of Improved Assay Performance With a Sensitive Assay for Cardiac Troponin I(2010)134 cited
- → Elderly Patients With Acute Coronary Syndromes Managed Without Revascularization(2013)134 cited